跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
RYBREVANT SC
Authorized
STANDARD
RYBREVANT SC
Janssen Inc
🇨🇦 Health Canada
Approval Date
Jun 23, 2026
Approval ID
bc39145957375955
Company
Janssen Inc
Type
Standard
Approval Details
Approval Id
bc39145957375955
Drug Approval Canada Name
RYBREVANT SC
Product Name
RYBREVANT SC
Status
Approved
Status Date
2026-06-18
Din
02569175
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
PRESCRIPTION , SCHEDULE D
Atc Original
L01FX18 AMIVANTAMAB
Aig Number
0163501002
Company Name
Janssen Inc
Company Address
19 Green Belt Drive Toronto Ontario Canada M3C 1L9
Company Detail Path
/organization/janssen-inc
Company Information
Pharmaceutical Company Name
Janssen Inc
Country Name
Canada
Province Name
Ontario
City Name
north york,ontario,country_ca
Address
19 Green Belt Dr
Active Ingredients
AMIVANTAMAB
3520 MG / 22 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jun 23, 2026
Approval ID
bc39145957375955
Type
Standard
Back to Health Canada Approvals
RYBREVANT SC - Health Canada Drug Approval Details